Effects of risk counseling on interest in breast cancer genetic testing for lower risk women

被引:31
作者
Bowen, DJ
Burke, W
Yasui, Y
McTiernan, A
McLeran, D
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[2] Univ Washington, Seattle, WA 98195 USA
关键词
genetic testing; risk information; breast cancer risk counseling;
D O I
10.1097/00125817-200209000-00007
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: A randomized trial was conducted to test the effects of two counseling methods (genetic counseling and group counseling) against a control no-intervention condition on interest in genetic testing in lower risk women. Methods: After completing baseline surveys, women (N = 357) were randomized to one of three conditions: to receive individual genetic risk counseling, to receive a group psychosocial group counseling, or to serve as a control group. Participants completed follow-up questionnaires 6 months after randomization. Results: All participants had some familial history of breast cancer, but none had a family history indicative of autosomal dominant genetic mutation. At baseline over three fourths of the sample judged themselves to be appropriate candidates for testing. By the end of the survey, two thirds (70%) of the women in the counseling group still judged themselves to be appropriate candidates for testing. Findings were similar for interest in genetic testing. Changes in beliefs about genetic testing (e.g., beliefs about potential stigma associated with testing) altered the effects of counseling. Conclusion: These results indicate that counseling can change interest in genetic testing only slightly and that changing women's beliefs about the properties of testing might be one mechanism of doing so.
引用
收藏
页码:359 / 365
页数:7
相关论文
共 20 条
[1]  
[Anonymous], 1998, Promoting Safe and Effective Genetic Testing in the United States
[2]  
Bowen D, 1999, CANCER EPIDEM BIOMAR, V8, P581
[3]  
Burke W, 2000, AM J MED GENET, V90, P361, DOI 10.1002/(SICI)1096-8628(20000228)90:5<361::AID-AJMG4>3.0.CO
[4]  
2-8
[5]  
Codori AM, 1999, CANCER EPIDEM BIOMAR, V8, P345
[6]  
COHEN MM, 1994, AM J HUM GENET, V55, pR1
[7]  
Collins FS, 1996, J CLIN ONCOL, V14, P1738
[8]   STATEMENT ON USE OF DNA TESTING FOR PRESYMPTOMATIC IDENTIFICATION OF CANCER RISK [J].
COLLINS, FS ;
BENJAMIN, LJ ;
BOTSTEIN, D ;
COX, JR ;
DAVIDSON, N ;
GRAY, JW ;
HOLTZMAN, N ;
HOUSMAN, DE ;
JAMISON, KR ;
NELKIN, D ;
ROTHSTEIN, R ;
SMITH, DC ;
SMITH, LM ;
SPENCE, MA ;
TILGHMAN, SM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (10) :785-785
[9]  
Durfy SJ, 1999, CANCER EPIDEM BIOMAR, V8, P369
[10]   PROJECTING INDIVIDUALIZED PROBABILITIES OF DEVELOPING BREAST-CANCER FOR WHITE FEMALES WHO ARE BEING EXAMINED ANNUALLY [J].
GAIL, MH ;
BRINTON, LA ;
BYAR, DP ;
CORLE, DK ;
GREEN, SB ;
SCHAIRER, C ;
MULVIHILL, JJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24) :1879-1886